Extending therapeutic options? Prospects for the future.
Edmeads
J G
JG
Department of Medicine, Sunnybrook Health Science Center, Toronto, Ont., Canada.
D002560:Cerebrovascular Circulation / Q000187:drug effects; D005544:Forecasting; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy* / Q000517:prevention & control; D010080:Oxazoles / Q000009:adverse effects / Q000627:therapeutic use*; D023303:Oxazolidinones; D017366:Serotonin Receptor Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D014276:Trigeminal Nerve / Q000187:drug effects; D014363:Tryptamines
D010080:Oxazoles; D023303:Oxazolidinones; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; C089750:zolmitriptan